Developmental outcomes of children exposed to antidepressants in pregnancy

被引:41
|
作者
Galbally, Megan [1 ]
Lewis, Andrew J. [2 ]
Buist, Anne [3 ]
机构
[1] Mercy Hosp Women, Heidelberg, Vic, Australia
[2] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia
来源
关键词
antidepressants; child development; pregnancy; IN-UTERO EXPOSURE; MATERNAL DEPRESSION; PRENATAL EXPOSURE; FLUOXETINE; SEROTONIN; LIFE; MEDICATIONS; CORTISOL; BEHAVIOR; MOTHERS;
D O I
10.3109/00048674.2010.549995
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the developmental outcomes in children exposed to antidepressants in utero and compare those to children not exposed to these medications Method: A prospective case-controlled study of children exposed to antidepressants in pregnancy assessed 22 exposed and 19 not exposed children using the Bayley Scales of Infant Development, third edition. The control group was measured at a mean age of 23.09 (SD 3.82) months and the medicated group at 28.53 months (SD 6.22). Maternal variables were assessed using a purpose-designed questionnaire and the Beck Depression Inventory (II) in pregnancy and at three assessments in the postpartum. Results: Children exposed to antidepressant medication in pregnancy scored lower on motor subscales in particular on fine motor scores than non-exposed children with a moderate effect size of Cohen's d = 0.47 fine motor and Cohen's d = 0.43 for gross motor. Due to lack of power these findings did not reach conventional criteria for statistical significance. There was no association found between maternal depression and neurodevelopment. Conclusions: This finding of a possible effect from antidepressant exposure in pregnancy on children's motor development is similar to the findings from a previous study. Future research is needed which assesses children at an older age using specific assessments of motor development.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 50 条
  • [21] Pregnancy Outcomes In Women Exposed To Golimumab
    Lau, Amy G.
    Clark, Michael
    Harrison, Diane D.
    Geldhof, Anja
    Nissinen, Riikka
    Sanders, Marilyn
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S870 - S871
  • [22] Risk of congenital malformations among infants exposed to antidepressants during pregnancy
    Davis, Robert L.
    Andrade, Susan
    Platt, Richard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (04) : 423 - 423
  • [23] The long-term neurodevelopmental outcomes of 13 children exposed to Lacosamide during pregnancy
    Dangot, Ayelet
    Warshaviak, Miriam
    Trigerman, Shai
    Lieber, Shir
    Goldstein, Lilac
    Fahum, Firas
    Klieger, Chagit
    NEUROTOXICOLOGY AND TERATOLOGY, 2024, 104
  • [24] Long-term outcomes of children exposed to RAAS-inhibitors during pregnancy
    Schink, Tania
    Braitmaier, Malte
    Haug, Ulrike
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 527 - 528
  • [25] Developmental Outcomes in Young Children Born to Mothers with West Nile Illness during Pregnancy
    Sirois, Patricia A.
    Pridjian, Gabriella
    McRae, Scott
    Hinckley, Alison F.
    Rasmussen, Sonja A.
    Kissinger, Patricia
    Buekens, Pierre
    Hayes, Edward B.
    O'Leary, Daniel R.
    Swan, Kenneth F.
    Xiong, Xu
    Wesson, Dawn M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (10) : 792 - 796
  • [26] Developmental outcomes in children born to women with possible subclinical rubella exposures during pregnancy
    Hutton, Jill
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
  • [28] PREGNANCY OUTCOMES IN WOMEN EXPOSED TO INFLIXIMAB (INNOVATOR)
    Slater, J.
    Phillips, J.
    Guo, C. -Y.
    Clark, M.
    Geldhof, A.
    Gearhart, N.
    Nissinen, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 496 - 496
  • [29] Pregnancy outcomes in women exposed to cancer chemotherapy
    Danet, Chloe
    Araujo, Melanie
    Bos-Thompson, Marie-Andree
    Portolan, Ghyslaine
    Gautier, Sophie
    Vanlemmens, Laurence
    Bonenfant, Sophie
    Jonville-Bera, Annie-Pierre
    Cottin, Judith
    Vial, Thierry
    Bavoux, Francoise
    Montastruc, Jean-Louis
    Damase-Michel, Christine
    Benevent, Justine
    Bourgeois-Mondon, Isabelle
    Lacroix, Isabelle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (12) : 1302 - 1308
  • [30] Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan
    Kawai, Yumi
    Tsuchiya, Tsuyoshi
    Aoki, Shigeru
    DIGESTIVE DISEASES, 2019, 37 (02) : 123 - 130